Synairgen announces completion of recruitment into its Phase II Home-Based COVID-19 study of inhaled interferon beta

Ads

You May Also Like

Emerald Health Therapeutics Secures Proprietary Extraction Technology and  Extraction Capabilities in Agreement with Indena

Emerald receives certain exclusive rights to established Phytosome® technology to enhance absorption and bioavailability ...

OncBioMune Selects Theradex as CRO for Two Phase 2 Trials of ProscaVax for Prostate Cancer

BATON ROUGE, La., March 08, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" ...

Importance of Smallpox Vaccination Highlighted in Biopreparedness Exercise

Conclusions from a tabletop exercise in Australia, simulating a smallpox outbreak in the Asia-Pacific, ...